GP1BA
protein-codingglycoprotein Ib platelet subunit alpha, the group of CD molecules
Gene summary
Glycoprotein Ib (GP Ib) is a platelet surface membrane glycoprotein composed of a heterodimer, an alpha chain and a beta chain, that is linked by disulfide bonds. The Gp Ib functions as a receptor for von Willebrand factor (VWF). The complete receptor complex includes noncovalent association of the alpha and beta subunits with platelet glycoprotein IX and platelet glycoprotein V. The binding of the GP Ib-IX-V complex to VWF facilitates initial platelet adhesion to vascular subendothelium after vascular injury, and also initiates signaling events within the platelet that lead to enhanced platelet activation, thrombosis, and hemostasis. This gene encodes the alpha subunit. Mutations in this gene result in Bernard-Soulier syndromes and platelet-type von Willebrand disease. The coding region of this gene is known to contain a polymophic variable number tandem repeat (VNTR) domain that is associated with susceptibility to nonarteritic anterior ischemic optic neuropathy. [provided by RefSeq, Oct 2013]
- GP1B
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008332
Submitter: ClinGen
GP1BA was first reported in relation to autosomal dominant platelet-type von Willebrand disease in 1991 (Miller JL, et al., 1991, PMID: 2052556). At least 7 unique variants have been reported in humans; six missense mutations, located within the VWF binding region and one 27 bp deletion in the macroglycopeptide region. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Variants in this gene have been reported in at least 23 probands in 18 publications (PMIDs: 26116638, 16704444, 23014764, 17916098, 26988807, 19951970, 9282797, 27683759, 14521605, 25985451, 2052556, 17264965, 15705799, 8384898, 27819553, 7833477, 17233824, 24474090). Variants in this gene segregated with disease in 31 additional family members. Platelet-type von Willebrand disease is an inherited bleeding disorder caused by heterozygous gain-of-function variants of GP1BA conferring enhanced affinity for von Willebrand factor to platelet integrin GPIbα. This disorder is characterized by a mild to moderate bleeding phenotype associated with fluctuating thrombocytopenia. This gene-disease relationship is supported by its function in primary hemostasis, binding vWF, functional alteration in patient cells (PMID: 9226170, 30655369), and a knock-in mouse model (PMID: 18187573). In summary, GP1BA is definitively associated with autosomal dominant platelet-type von Willebrand disease. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Of note this gene has also been implicated in Bernard-Soulier Syndrome. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanism (gain of function vs. loss of function), inheritance pattern (autosomal dominant vs. predominantly autosomal recessive), and phenotypic variability. Therefore, we have split curations for the disease entities platelet-type von Willebrand disease and Bernard-Soulier Syndrome; these gene-disease relationships have been assessed separately.
Inheritance Pattern: AD
Disease ID:MONDO:0015372
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009276
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0008332
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009276
Submitter: ClinGen
GP1BA was first reported in relation to autosomal recessive Bernard-Soulier syndrome in 1991 (Ware et al., PMID: 2308962). At least 45 unique variants (e.g. missense, nonsense, and frameshifts) have been reported in humans (PMID: 24934643). The unifying feature of all of the mutations is the ability of the mutation to disrupt the assembly and/or function of a surface-expressed GP Ib-IX-V complex. How individual mutations affect complex assembly or surface expression can be variable. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 10 probands in 10 publications (PMIDs: 9326230, 11054083, 16788318, 7873390, 19448529, 9639514, 7949089, 7579348, 17083647, 21993687). Variants in this gene segregated with disease in 6 additional family members. More evidence is available in the literature, but the maximum score for genetic evidence has been reached. This gene-disease association is supported by its biochemical function in the GP1b platelet receptor for VWF (PMID: 10669163), its interaction with GP1BB (PMID: 808914), a knock-out animal model (PMID: 10706630), and rescue of the animal model with wildtype GP1BA (PMID: 10706630, 22044935). In summary, GP1BA is definitively associated with autosomal recessive Bernard-Soulier syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Of note, this gene has also been implicated in autosomal dominant Bernard-Soulier syndrome (MONDO:0007930) characterized predominantly by macrothrombocytopenia. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found interfamilial phenotypic variability is observed between individuals harboring the same genetic variant between different inheritance patterns and the difference in the inheritance pattern for the disease entities is representative of a continuum of disease, i.e. mild carrier phenotypic features are observed in recessive disease (PMID: 25370924). Thus the disease entities were lumped and the well-established autosomal recessive inheritance pattern has been curated here; additional mono-allelic manifestations have also been reported (PMIDs: 21933849, 18815197, 26849716, 16519708, 7690774). Additionally, this gene has also been implicated in platelet-type von Willebrand disease. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanism (gain of function vs. loss of function), inheritance pattern (autosomal dominant vs. predominantly autosomal recessive), and phenotypic variability. Therefore, we have split curations for the disease entities platelet-type von Willebrand disease and Bernard-Soulier Syndrome; these gene-disease relationships have been assessed separately.
Inheritance Pattern: AD
Disease ID:MONDO:0008332
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009276
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009276
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007930
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0008332
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0009276
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007930
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: SD
Disease ID:MONDO:0009276
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0008332
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Hematologic
Intervention: Hematologic; Pharmacogenomic
Rationale: Preventive measures (eg, in the case of surgery) and treatment of bleeding episodes can be beneficial; Specific medications (eg, certain anesthetics) that interfere with platelet function should be avoided
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GP1BA variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000173.7. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 60 | 1 | 62 | ||
| missense | 9 | 23 | 178 | 19 | 4 | 233 |
| nonsense | 3 | 14 | 4 | 21 | ||
| start loss | 1 | 1 | ||||
| frameshift | 7 | 45 | 5 | 1 | 58 | |
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 19 | 82 | 189 | 80 | 5 | 375 |
Highest pathogenic variant AF is 0.00011030487
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000164.5 | 1 | MANE Select | |
| Ensembl | ENSP00000329380.5 | 1 | MANE Select | |
| Ensembl | ENSP00000807199.1 | 1 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Platelet activation - Homo sapiens (human)
- ECM-receptor interaction - Homo sapiens (human)
- Hematopoietic cell lineage - Homo sapiens (human)
- RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
- Gene expression (Transcription)
Biological Process
- cell morphogenesis
- cell adhesion
- cell surface receptor signaling pathway
- blood coagulation
- blood coagulation, intrinsic pathway
Molecular Function
- protein binding
- thrombin-activated receptor activity
Cellular Component
- extracellular space
- plasma membrane
- integral component of plasma membrane
- cell surface
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000329125
- Coding exons
- 1
- Length
- 2734
- Individuals with no LoFs
- 124505
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 148
- Defined
- 124653
- p
- 0.000594
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.303 | 368 | 352 | 1.05 | 0.0000208 | 4149 |
| Missense (PolyPhen) | 68 | 73.815 | 0.92122 | 941 | ||
| Synonymous | -0.811 | 178 | 165 | 1.08 | 0.0000105 | 1501 |
| Loss of Function | 0.463 | 4 | 5.13 | 0.779 | 2.67e-7 | 55 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00020 | 0.00019 | rare |
| Latino/Admixed American | 0.00021 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00050 | 0.00044 | rare |
| Finnish | 0.00079 | 0.00079 | rare |
| European (Non-Finnish) | 0.0011 | 0.00097 | notable |
| South Asian | 0.00010 | 0.000098 | rare |
| Other | 0.00069 | 0.00050 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: GP-Ib, a surface membrane protein of platelets, participates in the formation of platelet plugs by binding to the A1 domain of vWF, which is already bound to the subendothelium.;
- Disease
- DISEASE: Non-arteritic anterior ischemic optic neuropathy (NAION) [MIM:258660]: An ocular disease due to ischemic injury to the optic nerve. It usually affects the optic disk and leads to visual loss and optic disk swelling of a pallid nature. Visual loss is usually sudden, or over a few days at most and is usually permanent, with some recovery possibly occurring within the first weeks or months. Patients with small disks having smaller or non- existent cups have an anatomical predisposition for non-arteritic anterior ischemic optic neuropathy. As an ischemic episode evolves, the swelling compromises circulation, with a spiral of ischemia resulting in further neuronal damage. {ECO:0000269|PubMed:14711733}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Bernard-Soulier syndrome (BSS) [MIM:231200]: A coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, thrombocytopenia, and impaired prothrombin consumption. {ECO:0000269|PubMed:10089893, ECO:0000269|PubMed:1730088, ECO:0000269|PubMed:7690774, ECO:0000269|PubMed:7819107, ECO:0000269|PubMed:7873390, ECO:0000269|PubMed:9639514}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bernard-Soulier syndrome A2, autosomal dominant (BSSA2) [MIM:153670]: A coagulation disorder characterized by mild to moderate bleeding tendency, thrombocytopenia, and an increased mean platelet volume. Some individuals have no symptoms. Mild bleeding tendencies manifest as epistaxis, gingival bleeding, menorrhagia, easy bruising, or prolonged bleeding after dental surgery. {ECO:0000269|PubMed:11222377}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pseudo-von Willebrand disease (VWDP) [MIM:177820]: A bleeding disorder characterized by abnormally enhanced binding of von Willebrand factor by the platelet glycoprotein Ib (GP Ib) receptor complex. Hemostatic function is impaired due to the removal of VWF multimers from the circulation. {ECO:0000269|PubMed:14521605, ECO:0000269|PubMed:2052556, ECO:0000269|PubMed:8384898, ECO:0000269|PubMed:8486780}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.550
Intolerance Scores
- LoFtool
- 0.630
- RVIS EVS
- 0.14
- RVIS percentile EVS
- 63.62
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.883
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |